Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs Reportstack Reportstack Contact contactus@reportstack.com
Summary '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs'’, which provides in-depth analysis of breast cancer therapeutics market within the eight major geographies of the US, Canada, the top five geographies in Europe (the UK, France, Germany, Spain and Italy) and Japan. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. The breast cancer therapeutics market in the eight major markets - The US, The UK, France, Germany, Spain, Italy, Japan and Canada - was worth $9.2 billion in 2013, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.1% to $13.1 billion by 2020. The US had the largest market in 2013, valued at $5.5 billion, equivalent to a global share of 59%, followed by Japan with $871.5m or 9.4% and Italy with $668.5m or 7.2%. Canada had the lowest market share and value of the leading eight at 2.9% and $268.4m, but is expected to witness rapid growth over the forecast period with a CAGR of 6.7%. This will only be surpassed by Japan, which is expected to witness growth at a CAGR of 6.9%.
Reportstack Contact contactus@reportstack.com
Scope of the report
Disease overview, as well as treatment algorithms and treatment usage patterns
Market size and forecast for the breast cancer market from 2012 to 2019
Major marketed products for breast cancer along with a heat map of product performance
In-depth pipeline analysis for global pipeline in breast cancer along with clinical trial failure rate analysis
Key drivers and restraints that have had and are expected to have a significant impact upon the market
Key licensing and co-development agreements that could have impact on growth trends
Reportstack Contact contactus@reportstack.com
Key Benefits Align your product portfolio to the markets with high growth potential Develop market entry and expansion strategies by identifying the potential regions
and therapeutic segments poised for strong growth Devise a more effectively tailored country strategy through the understanding of key
drivers and barriers in the breast cancer therapeutics market Develop key strategic initiatives based upon an understanding of key focus areas
and leading companies Accelerate and strengthen your market position by identifying key companies for
mergers, acquisitions and strategic partnerships
Reportstack Contact contactus@reportstack.com
If you are interested...
Contact −
Sudha B
−
Email: contactus@reportstack.com
−
Ph:+1-888-789-6604
−
http://www.reportstack.com
Reportstack Contact contactus@reportstack.com